Prescription privileges for psychologists: A comprehensive review and critical analysis of current issues and controversies

CNS Drugs

Volumn 20, Issue 1, 2006, Pages 51-66

  Lavoie, Kim L ^a,b,c   Barone, Silvana ^a,c  

^a HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^b UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COST EFFECTIVENESS ANALYSIS; CURRICULUM; DRUG SAFETY; EMPIRICISM; GENERAL PRACTITIONER; HEALTH CARE SYSTEM; HUMAN; LEGAL ASPECT; MEDICAL PRACTICE; MEDICAL RESEARCH; MENTAL HEALTH SERVICE; NORTH AMERICA; PRESCRIPTION; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; REVIEW; UNITED KINGDOM; VALIDATION PROCESS;

HUMANS; LEGISLATION, DRUG; PRESCRIPTIONS, DRUG; PROFESSIONAL AUTONOMY; PSYCHOLOGY, CLINICAL; PSYCHOTROPIC DRUGS;

EID: 30344450442     PISSN: 11727047     EISSN: 11727047     Source Type: Journal    
DOI: 10.2165/00023210-200620010-00005     Document Type: Review

References (113)

1. Norfleet MA. Responding to society's needs: prescription privileges for psychologists. J Clin Psychol 2002; 58 (6): 599-610
2. DeLeon PH, Fox RE, Graham SR. Prescription privileges: psychology's next frontier. Am Psychol 1991 Apr; 46 (4): 384-93
3. DeLeon PH, Wiggins Jr JG. Prescription privileges for psychologists. Am Psychol 1996; 51 (3): 225-9
4. DeLeon PH, Sammons MT, Sexton JL. Focusing on society's real needs: responsibility and prescription privileges? Am Psychol 1995; 50: 1022-32
5. Scope of practice: psychologist prescribing legislation. American Psychiatric Association. 2003 May [online]. Available from URL: http://www.psych.org/advocacy_policy/leg_issues/prescribing_issues/ rxfactsheetam43003.pdf [Accessed 2005 Apr 22]
6. McFall RM. Training for prescriptions vs. prescriptions for training: where are we now? Where should we be? How do we get there? J Clin Psychol 2002; 58 (6): 659-76
7. Albee GW. Just say no to psychotropic drugs! J Clin Psychol 2002; 58: 635-48
8. Hayes SC, Walser RD, Bach P. Prescription privileges for psychologists: constituencies and conflicts. J Clin Psychol 2002; 58 (6): 697-708
9. Hayes SC, Blackledge JT. Creating an alternative to prescription privileges in the era of managed care. In: Hayes SC, Heiby EM, editors. Prescription privileges for psychologists: a critical appraisal. Reno (NV): Context Press, 1998: 261-78
10. Hayes SC, Heiby EM. Psychology's drug problem: do we need a fix or should we just say no? Am Psychol 1996; 51: 198-206
11. Hayes SC, Heiby EM, editors. Prescription privileges for psychologists: a critical appraisal. Reno (NV): Context Press, 1998
12. DeNelsky GY. Prescription privileges for psychologists: the case against. Prof Psychol Res Pr 1991; 22 (3): 188-93
13. McReynolds P. Lightner Witmer: a centennial tribute. Am Psychol 1996; 51: 237-40
14. Reisman JM. A history of clinical psychology. 2nd ed. New York: Hemisphere, 1991
15. Committee on Training in Clinical Psychology. Recommended graduate training program in clinical psychology. Am Psychol 1947; 2: 539-58
16. Miller JG. Clinical psychology in the Veterans Administration. Am Psychol 1946; 1: 181-9
17. Humphreys K. Clinical psychologists as psychotherapists: history, future, and alternatives. Am Psychol 1996; 51: 190-7
18. Gilgen AR. American psychology since World War II: a profile of the discipline. Westport (CT): Greenwood Press, 1982
19. Rosenbaum JF. Attitudes toward benzodiazepines over the years. J Clin Psychiatry 2005; 66 Suppl. 2: 4-8
20. Alford GS. Pharmacotherpay. In: Hersen M, Kazdin AE, Bellack AS, editors. The clinical psychology handbook. New York: Pergamon Press, 1983: 631-56
21. Bloom FE, Kupfer DJ, editors. Psychopharmacology: the fourth generation of progress. New York: Raven Press, 1995
22. Guaiana G, Barbui C, Hotopf M. Amitriptyline versus other types of pharmacotherapy for depression. Cochrane Database Syst Rev 2003; (2): CD004186
23. MacGillivray S, Arroll B, Hatcher S, et al. Efficacy and tolerability of selective serotonin reuptake inhibitors compared with tricyclic antidepressants in depression treated in primary care: systematic review and meta-analysis. BMJ 2003; 326: 1014
24. Nutt DJ. Overview of diagnosis and drug treatments of anxiety disorders. CNS Spectr 2005 Jan; 10 (1): 49-56
25. Ham P, Waters DB, Oliver MN. Treatment of panic disorder. Am Fam Physician 2005 Feb 15; 71 (4): 733-9
26. Katzman M. Venlafaxine in the treatment of anxiety disorders. Med Sci Monit 2004 Jul; 10 (7): CR288-93. Epub 2004 Jun 29
27. Lapid MI, Rummans TA. Evaluation and management of geriatric depression in primary care. Mayo Clin Proc 2003; 78: 1423-9
28. Manning JS. Difficult-to-treat depressions: a primary care perspective. J Clin Psychiatry 2003; 64 Suppl. 1: 24-31
29. Remick RA. Diagnosis and management of depression in primary care: a clinical update and review. CMAJ 2002 Nov; 167 (11): 1253-60
30. Hansen DG, Vach W, Rosholm JU, et al. Early discontinuation of antidepressants in general practice: association with patient and prescriber characteristics. Fam Pract 2004 Dec; 21 (6): 623-9
31. Zimmerman MA, Wienckowski LA. Revisiting health and mental health linkages: a policy whose time has come...again. J Public Health Policy 1991; 12: 510-24
32. Christiansen A, Jacobson NS. Who (or what) can do psychotherapy: the status and challenge of nonprofessional therapies. Psychol Sci 1994; 5: 8-14
33. Dawes RM. House of cards. New York: Free Press, 1994
34. Cummings NA. Impact of managed care on employment and training: a primer for survival. Prof Psychol Res Pr 1995; 26: 10-5
35. Chiefetz DI, Salloway JC. Patterns of mental health services provided by HMOs. Am Psychol 1984; 39: 495-502
36. Egli D. Psychopharmacology in independent practice: prescription privileges [letter]. The Independent Practitioner 1994b; 14: 218
37. Drug sales globally continue to increase. IMS Health; 2002 Aug [online]. Available from URL: http://www.chiropractichelps/com/drgsalesgctoinc.html [Accessed 2005 May 7]
38. Brentar J, McNamara JR. Prescription privileges for psychologists: the next step in its evolution as a profession. Prof Psychol Res Pr 1991; 22: 194-5
39. Health Canada. The regulation of prescription drugs: roles and responsibilities. Health Canada Online; 2004 May [online]. Available from URL: http://www.hc-sc.gc.ca/english/media/releases/2004/internet_pharmacybk1.htm [Accessed 2005 Apr 22]
40. National Health Service Modernisation Agency, Department of Health. Medicines matters: a guide to current mechanisms for the prescribing, supply and administration of medicines [online]. Available from URL: http://www.content. modern.nhs.uk/cmsWISE/Workforce+Themes/Using_Task_Skills_Effectively/ workingsafely/prescribing/prescribing.htm [Accessed 2005 Apr 22]
41. Dozois DJ, Dobson KS. Should Canadian psychologists follow the APA trend and seek prescription privileges? A reexamination of the (r)evolution. Can J Psychol 1995 Nov; 36 (4): 288-304
42. Lavoie KL, Fleet RP. Should psychologists be granted prescription privileges? A review of the prescription privilege debate for psychiatrists. Can J Psychiatry 2002 Jun; 47 (5): 443-9
43. Sussman S. Re: should psychologists be granted prescription privileges? A review of the prescription privilege debate for psychiatrists [letter]. Can J Psychiatry 2003 Aug; 48 (7): 497-8
44. Williams-Nickelson C. Prescription privileges fact sheet: what students should know about the APA's pursuit of prescription privileges for psychologists (RxP). APA Practice Directorate, APA Monitor 2002
45. Sammons MT, Olmedo E. The prescription privileges agenda in 1997: forward progress, future goals. Prof Psychol Res Pr 1997 Dec; 28 (6): 507-8
46. Americal Psychological Association - Practice Directorate. New Mexico governor signs landmark law on prescription privileges for psychologists. APA Practice Directorate. In: The APA/Division Dialogue 2002 May/Jun [online]. Available from URL: http://www.apa.org/about/division/practicemay02.html [Accessed 2005 Apr 11]
47. Sammons MT, Brown AB. The department of defense psychopharmacology demonstration project: an evolving program for postdoctoral education in psychology. Prof Psychol Res Pr 1997 Apr; 28 (2): 107-12
48. Murray B. A brief history of RxP. APA Monitor 2003; 34: 66
49. Daw Holloway J. Psychologists persevere in the states. APA Monitor 2003; 34: 28
50. Holloway J. New Mexico becomes first state to gain Rx privileges. APA Monitor 2002; 33: 1
51. Daw Holloway J. Louisiana grants psychologists prescriptive authority. APA Monitor 2004; 35: 1
52. Dittman M. Psychology's first prescribers. APA Monitor 2003; 34: 36
53. Daw Holloway J. Steady and strong progress in the push for Rx privileges. APA Monitor 2002; 33: 1
54. Ax RK, Forbes MR, Thompson D. Prescription privileges for psychologists: a survey of predoctoral interns and directors of training. Prof Psychol Res Pr 1997 Dec; 28 (6): 509-14
55. Cullen EA, Newman R. In pursuit of prescription privileges. Prof Psychol Res Prac 1997 Apr; 28 (2): 101-6
56. Fox RE. Prescription privileges: their implications for the practice of psychology. Psychotherapy 1988; 25: 501-7
57. Fisher K, Buie J. Prescription privilege points, counterpoints debated at convention. APA Monitor 1987; 11: 6-7
58. Wiggins JG. The care for prescription privileges for psychologists. Psychotherapy in Private Practice 1992; 11: 3-8
59. Welsh RS. To medicate or not to medicate: let us be honest about why we should [letter]. Am Psychol 1992; 47: 1678
60. American Psychiatric Association. Scope of practice: psychologist prescribing legislation American Psychiatric Association 2003 May [online]. Available from URL: http:// www.psych.org/advocacy_policy/leg_issues/ prescribing_issues/rxfactsheetam43003.pdf [Accessed 2005 Apr 6]
61. Hausman K. Nurse practitioners in NY allowed to diagnose, prescribe. Psychiatr News 1988; 9: 11-2
62. Lazarus JA. Implications for medication errors and patient safety. Psychiatr Serv 2004 Dec; 55 (12): 1423-4
63. Dobson KS, Dozois DJA. Professional psychology and the prescription debate: still not ready to go to the altar. Can J Psychol 2001 May; 42 (2): 131-5
64. Plante TG, Boccaccini M, Andersen E. Attitudes concerning professional issues impacting psychotherapy practice among members of the American Board of Professional Psychology. Psychotherapy: Theory, Research, and Practice 1998; 35 (1): 34-42
65. Narrow WE. One-year prevalence of mental disorders, excluding substance use disorders, in the US: NIMH ECA prospective data. Population estimates based on US Census estimated residential population age 18 and over on July 1, 1998. (Data on file)
66. US Department of Health and Human Services. Mental health: a report of the surgeon general. Rockville (MD): US Department of Health and Human Services, 1999
67. US Department of Health and Human Services. The President's new freedom commission on mental health: achieving the promise: transforming mental health care in America. Rockville (MD): US Department of Health and Human Services, 2003
68. American Psychiatric Association. Resident matching numbers appear to have plateaued. Psychiatr News, 1998 Apr 3
69. Marra T. Should clinical psychologists have prescription privileges in California [letter]? Psychiatric Times 1994 Feb 20; 3: 20
70. Fulgieri MD. Prescription privileges for psychologists: an examination of the development of consumer attitudes [dissertation]. Dissertation Abstract International: Section B: The Sciences & Engineering, 2000 Aug; 62 (2-B): 1080
71. Staff. Nurses, other professional want bigger share. Bigger Roles 1993 Apr; 3, 7, 8, 23
72. DeLeon PH. Prescription privileges: evolutions within the APA governance. National Register for Archives and Manuscripts 1993; 1-10
73. Pimental PA, Stout CE, Hoover MS, et al. Changing psychologists' opinions about prescriptive authority: a little information goes a long way. Prof Psychol Res Pr 1997; 28: 123-7
74. McGrath E, Keita GP, Strickland BR, et al., editors. Women and depression: risk factors and treatment issues: final report of APA national task force on women and depression. Washington, DC: American Psychological Association, 1990
75. Moran M, Thompson T, Nies A. Sleep disorders in the elderly. Am J Psychiatry 1988; 145: 1369-78
76. De Las Cuevas C, Sanz EJ. Controversial issues associated with the prescription of benzodiazepines by general practitioners and psychiatrists. Med Sci Monit 2004; 10 (7): 288-93
77. Bell PF, Digman Jr RH, McKenna JP. Should psychologists obtain prescribing privileges? A survey of family physicians. Prof Psychol Res Pr 1995; 26 (4): 371-6
78. McGill Faculty of Medicine [online]. Available from URL: http://www.medicine.mcgill.ca/ [Accessed 2005 Apr 22]
79. University of Toronto Faculty of Medicine [online]. Available from URL: http://www.facmed.utoronto.ca/scripts/index_.asp [Accessed 2005 Apr 22]
80. GPs get new anti-depressant rules. BBC News UK edition; 2004 Dec [online]. Available from URL: http://news.bbc.co.uk/1/hi/health/4071145.stm [Accessed 2004 Dec 6]
81. Sweet JJ, Rozensky RH, Tovian SM, editors. Handbook of clinical psychology in medical settings. New York: Plenum, 1992
82. Smith BS. Attitudes toward prescribing privileges among clinical graduate students. Terre Haute (IN): Indiana State University, 1992. (Data on file)
83. Walters GD. A meta-analysis of opinion data on the prescription privilege debate. Can Psychol 2001 May; 42 (2): 119-25
84. deMayo RA. Academic interests and experiences of doctoral students in clinical psychology: implications for prescription privilege training. Prof Psychol Res Pr 2002; 33 (5): 499-501
85. St-Pierre ES, Melnyk WT. The prescription privilege debate in Canada: the voices of today's and tomorrow's psychologists. Can J Psychol 2004; 45 (4): 284-92
86. Kinderman P. Prescription rights: are we ready for change? [letter]. Psychologist 2003 Jun; 16 (6): 287-8
87. Orford J. Prescription rights peer commentary: don't go there [letter]. Psychologist 2003 Apr; 16 (4): 189
88. Johnston L. Prescription rights: peer commentary: back to basics [letter]. Psychologist 2003 Apr; 16 (4): 186
89. Gutierrez PM, Silk KR. Precription privileges for psychologists: a review of the psychological literature. Prof Psychol Res Pr 1998; 29: 213-22
90. Wagner MK. The high cost of prescription privileges. J Clin Psychol 2002; 58 (6): 677-80
91. Weiner J. Editorial. Psychiatric News 1995; 30: 5
92. Yates DF. Should psychologists have prescribing authority? A psychologist's perspective. Psychiatr Serv 2004 Dec; 55 (12): 1420-1
93. DoD Prescribing Psychologists: external analysis, monitoring, and evaluation of the program and its participants. Nashville (TN): American College of Neuropsychopharmacology, 1998
94. Prescribing Psychologists: DoD demonstration: participants perform well but have little effect on readiness or costs. Pub GAO/HEHS-99-98. Washington, DC: US General Accounting Office, 1999
95. Buie J. Practice priorities: Medicare amendments, hospital privileges, HMO reforms, prescription privileges. APA Monitor 1988; 1: 14-5
96. Peterson DR. Making psychology indispensable. Appl Prev Psychol 1996; 5: 1-8
97. Caccavale J. Opposition to prescriptive authority: is this a case of the tail wagging the dog? J Clin Psychol 2002; 58 (6): 623-33
98. Kaplan HI, Sadock BJ, editors. Synopsis of psychiatry. 8th ed. Maryland: Williams and Wilkens, 1998
99. Dittmann M. State Leadership Conference. Prescriptive authority: DoD-trained psychologists spoke about how prescribing has changed clinical practice. APA Monitor 2004 May; 35: 5
100. Antonuccio DO, Thomas M, Danton WG. A cost-effectiveness model: is pharmacotherapy really less expensive than psychotherapy for depression. In: Hayes SC, Heiby EM, editors. Prescription privileges for psychologists: a critical appraisal. Reno (NV): Context Press, 1998
101. DeRubeis RJ, Hollon SD, Amsterdam JD, et al. Cognitive therapy vs medications in the treatment of moderate to severe depression. Arch Gen Psychiatry 2005 Apr; 62 (4): 409-16
102. Antonuccio DO, Danton WG, DeNelsky GY, et al. Raising questions about antidepressants. Psychother Psychosom 1999; 68: 3-14
103. Antonuccio DO, Danton WG, DeNelsky GY. Psychotherapy versus medication for depression: challenging the conventional wisdom with data. Prof Psychol Res Pr 1995; 26 (6): 574-85
104. DeRubeis RD, Crits-Christoph P. Empirically supported individual and group psychological treatments for adult mental disorders. Consult Clin Psychol 1998 Feb; 66 (1): 37-52
105. Hollon SD, DeRubeis RJ, Shelton RC, et al. Prevention of relapse following cognitive therapy vs medications in moderate to severe depression. Arch Gen Psychiatry 2005 Apr; 62 (4): 417-22
106. Evans MS, Hollon SD, DeRubeis RJ, et al. Differential relapse following cognitive therapy and pharmacotherapy for depression. Arch Gen Psychiatry 1992 Oct; 49 (10): 802-8
107. Anderson BL. Biobehavioral outcomes following psychological interventions for cancer patients. J Consult Clin Psychol 2002; 70 (3): 590-610
108. Fawzy FI, Kemeney ME, Fawzy NW, et al. A structured psychiatric intervention for cancer patients. Arch Gen Psychiatry 1990; 47: 729-35
109. Halley FM. Self-regulation of the immune system through biobehavioural strategies. Biofeedback Self Regul 1999; 16: 55-73
110. Berkowitz RI, Wadden T, Tershakovec AM, et al. Behavior therapy and sibutramine for the treatment of adolescent obesity: a randomized controlled trial. JAMA 2003 Apr 9; 289 (14): 1805-12
111. Linden W, Stossel C, Maurice J. Psychosocial interventions for patients with coronary artery disease: a meta-analysis. Arch Intern Med 1996; 156: 745-52
112. Guiry E, Conroy RM, Hickey N, et al. Psychological response to an acute coronary event and its effect on subsequent rehabilitation and lifestyle change. Clin Cardiol 1987; 10: 256-60
113. Kelly JA, Kalichman SC. Behavioral research in HIV/AIDS primary and secondary prevention: recent advances and future directions. J Consult Clin Psychol 2002; 70 (3): 626-39